Elevance Health Inc. (ELV) Earnings History
Annual and quarterly earnings data from 2001 to 2025
Loading earnings history...
ELV EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ELV Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 25.6% | 4.1% | 2.8% |
| 2024 | 27.9% | 5.0% | 3.4% |
| 2023 | 27.4% | 5.1% | 3.5% |
| 2022 | 25.5% | 5.4% | 3.8% |
| 2021 | 26.0% | 6.5% | 4.4% |
Download Data
Export ELV earnings history in CSV or JSON format
Free sign-in required to download data
Elevance Health Inc. (ELV) Earnings Overview
As of May 6, 2026, Elevance Health Inc. (ELV) reported trailing twelve-month net income of $5.24B, reflecting -2.2% year-over-year growth. The company earned $23.79 per diluted share over the past four quarters, with a net profit margin of 2.8%.
Looking at the long-term picture, ELV's 5-year EPS compound annual growth rate (CAGR) stands at +6.9%, showing solid earnings momentum. The company achieved its highest annual net income of $6.10B in fiscal 2021.
Elevance Health Inc. maintains positive profitability with a gross margin of 25.6%, operating margin of 4.1%, and net margin of 2.8%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including UNH ($12.04B net income, 2.7% margin), CVS ($1.77B net income, 0.4% margin), CI ($6.29B net income, 2.2% margin), ELV has outperformed on profitability metrics. Compare ELV vs UNH →
ELV Earnings vs Peers
Earnings metrics vs comparable public companies
ELV Historical Earnings Data (2001–2025)
25 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.66B | -5.3% | $8.11B | $25.12 | 2.8% | 4.1% |
| 2024 | $5.98B | -0.1% | $8.89B | $25.68 | 3.4% | 5.0% |
| 2023 | $5.99B | +1.6% | $8.74B | $25.22 | 3.5% | 5.1% |
| 2022 | $5.89B | -3.4% | $8.45B | $24.28 | 3.8% | 5.4% |
| 2021 | $6.10B | +33.5% | $8.95B | $24.73 | 4.4% | 6.5% |
| 2020 | $4.57B | -4.9% | $7.71B | $17.98 | 3.8% | 6.3% |
| 2019 | $4.81B | +28.2% | $6.73B | $18.47 | 4.6% | 6.5% |
| 2018 | $3.75B | -2.4% | $5.84B | $14.19 | 4.1% | 6.3% |
| 2017 | $3.84B | +55.6% | $4.99B | $14.35 | 4.3% | 5.5% |
| 2016 | $2.47B | -3.5% | $5.42B | $9.21 | 2.9% | 6.4% |
Full ELV Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ELV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ELV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ELV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonELV — Frequently Asked Questions
Quick answers to the most common questions about buying ELV stock.
Is ELV growing earnings?
ELV EPS of $23.79 reflects slowing growth at -2.2%, below the 5-year CAGR of +6.9%. TTM net income is $5.2B. Expansion rate has moderated.
What are ELV's profit margins?
Elevance Health Inc. net margin is +2.8%, with operating margin at +4.1%. Below-average margins reflect competitive or cost pressures.
How consistent are ELV's earnings?
ELV earnings data spans 2001-2025. The current earnings trend is -2.2% YoY. Historical data enables comparison across business cycles.